EndoChoice Holdings, which sells gastrointestinal endoscopy systems with wide field-of-view cameras, raised $95 million by offering 6.4 million shares at $15, the low end of the range of $15 to $17. EndoChoice Holdings plans to list on the NYSE under the symbol GI. EndoChoice Holdings initially filed confidentially on 1/9/2015. J.P. Morgan and BofA Merrill Lynch acted as lead managers on the deal.
